Follow up idea, see related idea
After 5 wave impulse down and two month accumulation phase below IPO level sideways,
expect trend reversal into bull market, the downtrend channel got broken and tested on weekly timeframe.
The first human got crispered in china. USA will follow in 2017, I speculate on public awareness and solid growth, maybe hype.
In case of bull market, we got the possible pitchfork
After 5 wave impulse down and two month accumulation phase below IPO level sideways,
expect trend reversal into bull market, the downtrend channel got broken and tested on weekly timeframe.
The first human got crispered in china. USA will follow in 2017, I speculate on public awareness and solid growth, maybe hype.
In case of bull market, we got the possible pitchfork
코멘트:
and back above IPO!!! i love it <3
코멘트:
look for rsi breakout into new highs, consolidation above 18$ would confirm reversal.
코멘트:
Wyckoff scenario
코멘트:
wyckoff playing out nicely, can buy on dips for reaccumulation 16-17$ range
trailing stop below pitchfork, this stock keeps giving for weeks now with great volatility
trailing stop below pitchfork, this stock keeps giving for weeks now with great volatility
코멘트:
made a little indicator to compare EDIT price with the BTK biotech index
At ipo the indicator is 0, values below 0 indicates that EDIT is undervalued compared to biotech index, values over 0 indicates EDIT is overvalued compared to biotech index. Also showing the MA20 of this line (black).
At ipo the indicator is 0, values below 0 indicates that EDIT is undervalued compared to biotech index, values over 0 indicates EDIT is overvalued compared to biotech index. Also showing the MA20 of this line (black).
코멘트:
more media attention
www.wired.co.uk/arti...-technique-explained
www.wired.co.uk/arti...-technique-explained
코멘트:
crispr again in the news after
코멘트:
crispr again on all news sites after National Academy of Sciences releases Report "Human Genome Editing: Science, Ethics, and Governance"
코멘트:
CRISPR patent goes to Broad Institute of Cambridge -> EDIT www.technologyreview...-to-broad-institute/
코멘트:
pitchfork still intact!
wyckoff scenario also playing out as expected :-)
wyckoff scenario also playing out as expected :-)
코멘트:
Editas Medicine announces that its offering of 4M shares priced at $22.50 per share.
seekingalpha.com/new...-prices-90m-offering
resistance 0.5 fib keylevel at 28.20
Support 20.00-22.50
seekingalpha.com/new...-prices-90m-offering
resistance 0.5 fib keylevel at 28.20
Support 20.00-22.50
코멘트:
doubled my position here
코멘트:
this should be a bear trap, new chart on linear scale
